ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FHTX Foghorn Therapeutics Inc

5.24
-0.37 (-6.60%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Foghorn Therapeutics Inc FHTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.37 -6.60% 5.24 10:00:00
Open Price Low Price High Price Close Price Previous Close
5.60 5.08 5.60 5.25 5.61
more quote information »

Recent News

Date Time Source Heading
04/6/202406:02EDGAR2Form 8-K - Current report
28/5/202421:00GLOBEFoghorn Therapeutics to Participate in Upcoming Investor..
23/5/202421:03EDGAR2Form 8-K - Current report
23/5/202408:21GLOBEFoghorn Therapeutics Raises Approximately $110 Million..
23/5/202406:05EDGAR2Form 8-K - Current report
21/5/202406:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/5/202422:02EDGAR2Form 8-K - Current report
07/5/202406:54EDGAR2Form 8-K - Current report
06/5/202421:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202421:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/5/202421:03EDGAR2Form 8-K - Current report
07/3/202423:11EDGAR2Form 8-K - Current report
07/3/202423:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/2/202423:04EDGAR2Form 8-K - Current report
26/1/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202408:09EDGAR2Form 8-K - Current report
08/1/202423:04EDGAR2Form 8-K - Current report
04/1/202408:18EDGAR2Form 8-K - Current report
28/11/202311:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202322:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202322:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202322:03EDGAR2Form 8-K - Current report
02/11/202301:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11/9/202320:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08/9/202321:04EDGAR2Form 8-K - Current report
05/9/202322:00GLOBEFoghorn Therapeutics Announces Participation in Upcoming..
31/8/202321:04EDGAR2Form 8-K - Current report
31/8/202321:00GLOBEFoghorn Therapeutics Announces First Patient Dosed in Phase..
29/8/202323:00PRNUSInvaio achieves first registration for citrus greening..
19/8/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202306:08EDGAR2Form 8-K - Current report
08/8/202321:05EDGAR2Form 8-K - Current report
08/8/202321:00GLOBEFoghorn Therapeutics Announces Chief Medical Officer..
04/8/202321:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202321:05EDGAR2Form 8-K - Current report
04/8/202321:00GLOBEFoghorn Therapeutics Provides Second Quarter 2023 Financial..
28/6/202321:00GLOBEFoghorn Therapeutics Announces Clinical Data from Phase 1..

Your Recent History

Delayed Upgrade Clock